NW corporate results: Targeted Genetics
NW CORPORATE RESULTS | Dollar figures in thousands, except per share; parentheses denote losses. Targeted Genetics Biotechnology Dec. 31 % 4th QTR...
|
|
|
| Dollar figures in thousands, except per share; parentheses denote losses. |
|
| Targeted Genetics |
| Biotechnology |
|
Dec. 31 |
|
% |
| 4th QTR |
2007 |
2006 |
CHG |
| Profit |
($5,073) |
$808 |
|
| Per share |
(0.26) |
0.08 |
|
| Revenue |
3,220 |
4,008 |
-19.7 |
| ANNUAL |
2007 |
2006 |
CHG |
| Profit |
($16,127) |
($33,990) |
+52.6 |
| Per share |
(0.98) |
(3.47) |
+71.8 |
| Revenue |
10,332 |
9,864 |
+4.7 |
| COMMENT: The Seattle biotech firm swung to a quarterly loss on higher research-and-development expenses. |